RE/MAX Merger Clears HSR Antitrust Review, Path to Close Narrows
RMAX sits 94% above its 52-week low of $5.46.
Summary
RE/MAX's pending acquisition by The Real Brokerage cleared U.S. antitrust review on July 13, 2026, satisfying a key closing condition ahead of the August 14 shareholder votes.
Key Events · M&A and Partnerships · RMAX
-
HSR Antitrust Clearance Obtained
On July 13, 2026, the U.S. Department of Justice granted early termination of the Hart-Scott-Rodino waiting period, removing a key regulatory condition for the merger with The Real Brokerage.
-
Merger Timeline Advances
With HSR clearance now secured, the remaining major conditions are stockholder approvals from both RE/MAX and Real Brokerage, with votes scheduled for August 14, 2026.
-
Deal Background
The merger agreement was announced on April 26, 2026, and the definitive proxy was filed on July 9, 2026. HSR filings were made in May, withdrawn and refiled in June, leading to this early termination.
Analysis · RMAX · Real Estate & Construction
A major regulatory hurdle fell away on July 13, 2026, when the U.S. Department of Justice granted early termination of the HSR waiting period for RE/MAX's acquisition by The Real Brokerage. With the definitive proxy already on file and shareholder votes locked in for August 14, this clearance materially de-risks the deal. The merger, first announced in April, still needs stockholder approvals from both companies, but antitrust clearance was a key gating item. Attention now turns to the vote outcome and integration execution.
At the time of this filing, RMAX was trading at $10.61 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $359.1M. The 52-week trading range was $5.46 to $11.81. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.